Ultra-high-throughput Screening

Ultra-High-Throughput Screening is a high-throughput experimental methodology in drug discovery and functional genomics that distinguishes itself by enabling the rapid, automated testing of millions to billions of chemical or biological compounds per day to identify active agents against specific molecular targets.

141

Publications

8.8K

Citations

898

Authors

264

Institutions

Publications per year

2017–2026

51

Variants

Uhts

Authors

898

  1. FH
    Florian Hollfelder

    University of Cambridge, United Kingdom

    7 publications · 447 citations

    7

    h-index

  2. BS
    Berta Strulovici

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    6 publications · 182 citations

    6

    h-index

  3. OK
    Oleg Kornienko

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    5 publications · 160 citations

    5

    h-index

  4. AJ
    Andrew J. Pope

    GlaxoSmithKline (United Kingdom), United Kingdom

    5 publications · 211 citations

    5

    h-index

  5. DA
    David A. Dunn

    Auburn University, United States

    4 publications · 190 citations

    4

    h-index

1–5 of 898

Venues

  1. SLAS DISCOVERY

    19 publications · 813 citations

    17

    h-index

  2. Assay and Drug Development Technologies

    10 publications · 380 citations

    10

    h-index

  3. Drug Discovery Today

    6 publications · 312 citations

    6

    h-index

  4. Scientific Reports

    5 publications · 208 citations

    5

    h-index

  5. PLoS ONE

    4 publications · 190 citations

    4

    h-index

1–5